Khallat Abu Ḥalaḥ: A Byzantine-Period Structure at Ramot Menashe / ח'לת אבו חלאח: מבנה מן התקופה הביזנטית ברמות מנשה
Qadum: Journal of Excavation Reports from Israel · 19.08.2025 · 1 (1) · 1-34
DOI: 10.70967/3078-8528.1041 ↗Kurz gefasst
Fachartikel in der Zeitschrift Qadum: Journal of Excavation Reports from Israel, online erschienen am 19.08.2025. Verfasst von Ron Be'eri.
Abstract (Originalsprache)
The excavation at Khallat Abu Ḥalaḥ uncovered part of a Byzantine-period structure comprising several rectangular rooms, corresponding to five construction phases. One of these rooms may have functioned as a bathhouse. Remains of another nearby structure decorated with a cross were also revealed, along with the upper fragment of a small chalkstone altar incised with a cross; a road paved with small stones and flanked by two walls that led to the site and continued toward Naḥal Dalia; and several field walls, one of which may have served as an enclosure. The finds from the site—including a fragment of a marble chancel screen incised with a cross within a medallion and the altar fragment decorated with a cross—indicate that the site was inhabited by a Christian population, likely part of the agricultural hinterland of Caesarea.
Zitieren
APA
Be'eri, R. (2025). Khallat Abu Ḥalaḥ: A Byzantine-Period Structure at Ramot Menashe / ח'לת אבו חלאח: מבנה מן התקופה הביזנטית ברמות מנשה. Qadum: Journal of Excavation Reports from Israel, 1(1), 1-34. https://doi.org/10.70967/3078-8528.1041
Vancouver
Be'eri R. Khallat Abu Ḥalaḥ: A Byzantine-Period Structure at Ramot Menashe / ח'לת אבו חלאח: מבנה מן התקופה הביזנטית ברמות מנשה. Qadum: Journal of Excavation Reports from Israel. 2025;1(1):1-34. doi:10.70967/3078-8528.1041
BibTeX
@article{Beeri2025,
author = {Be'eri, Ron},
title = {Khallat Abu Ḥalaḥ: A Byzantine-Period Structure at Ramot Menashe / ח'לת אבו חלאח: מבנה מן התקופה הביזנטית ברמות מנשה},
journal = {Qadum: Journal of Excavation Reports from Israel},
year = {2025},
volume = {1},
number = {1},
pages = {1--34},
doi = {10.70967/3078-8528.1041}
}
EUVIMED